Vaccines

Primary tabs

Thu, 2015-01-08 20:48 — mdmcdonald

Information on vaccines to counter Ebola and other diseases

The Mission of this group is to follow the development of vaccines and other medications to counter Ebola and other diseases.

Add Content to this group

Click to add a new Group Post Simple to this group
Click to add a new Group Post Simple w Images to this group
Click to add a new Group Post to this group
Click to add a new PRIVATE Group Post to this group
Click to add a new TASK to this group

Members

Kathy Gilbeaux

mdmcdonald

MDMcDonald_me_com

mike kraft

Subscribe to group

Email address for group

vaccines_global@m.resiliencesystem.org

U.S. expected to provide additional 500 million Pfizer-BioNTech doses to 100 nations over the next year

Wed, 2021-06-09 14:24 — mike kraft

The U.S. is expected to provide 500 million Pfizer-BioNTech doses to 100 nations over the next year

The White House has reached an agreement with Pfizer and BioNTech to provide 500 million doses of coronavirus vaccine to about 100 countries over the next year, a pact that President Biden plans to announce as early as Thursday, according to multiple people familiar with the plan.

Under intense pressure to do more to address the global vaccine shortage and the disparities in vaccination between rich and poor nations, the president hinted at the plan Wednesday morning, when he was asked if he had a vaccination strategy for the world.

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

J&J COVID-19 vaccine protects against virus variants--new study

Wed, 2021-06-09 12:15 — mike kraft

Johnson & Johnson COVID-19 vaccine protects against virus variants, study shows In the new study, Harvard researchers who developed the J&J COVID-19 vaccine found it protected against severe disease regardless of the variant. Karen Weintraub USA TODAY

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about J&J COVID-19 vaccine protects against virus variants--new study
Log in or register to post comments

Analysis: Wary of Russian vaccine, Brazil plans its own additional study for more safety data

Wed, 2021-06-09 12:03 — mike kraft

Analysis: Still wary of Russian vaccine, Brazil clears its own 'study' for more data Russian vaccine developers cheered hard-won access to Brazil's market last week, but with less than a million doses cleared for import, public health experts say the approval is more like a late-stage trial for the Sputnik V shot. Lisandra Paraguassu Reuters

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about Analysis: Wary of Russian vaccine, Brazil plans its own additional study for more safety data
Log in or register to post comments

Millions of Johnson & Johnson COVID-19 vaccines are set to expire this month, and states are scrambling; White House says only small fraction will be unused

Wed, 2021-06-09 10:16 — mike kraft

Millions of Johnson & Johnson COVID-19 vaccines are set to expire this month, and states are scrambling to use up their stockpiles or send them abroad US states are racing to use up stocks of the Johnson & Johnson vaccine, or send them elsewhere. Public opinion of the shot has soured. Grace Dean YahooNews

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

SARS-CoV-2 Delta variant: Pfizer-BioNTech vaccine recipients have lower antibody levels

Tue, 2021-06-08 22:30 — mike kraft

SARS-CoV-2 Delta variant: Pfizer-BioNTech vaccine recipients have lower antibody levels - Outbreak News Today Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health […] Press Release Outbreak News Today

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Analysis

Situation Report

Read more about SARS-CoV-2 Delta variant: Pfizer-BioNTech vaccine recipients have lower antibody levels
Log in or register to post comments

Mastercard Foundation to spend $1.3B for COVID vaccinations for Africa \

Tue, 2021-06-08 20:34 — mike kraft

Foundation to spend $1.3B to vaccinate Africans for COVID One of the world's largest foundations will spend $1.3 billion over the next three years to acquire and deliver COVID-19 vaccines for more than 50 million people in Africa. It’s a first-of-its-kind effort for a Western nonprofit to bolster Africa’s lagging vaccination campaign amid widespread fears of a third wave of infections on the continent. AP NEWS

Country / Region Tags:

Africa

Canada

Conakry

Democratic Republic of the Congo

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Mastercard Foundation to spend $1.3B for COVID vaccinations for Africa \
Log in or register to post comments

US increasingly unlikely to meet Biden’s July 4 vaccination goal

Tue, 2021-06-08 20:13 — mike kraft

US increasingly unlikely to meet Biden's July 4 vax goal WASHINGTON (AP) — For months, President Joe Biden has laid out goal after goal for taming the coronavirus pandemic and then exceeded his own benchmarks. Now, though, the U.S. is unlikely to meet his target to have 70% of Americans at least partially vaccinated by July 4. AP NEWS

Country / Region Tags:

General Topic Tags:

Problem, Solution, SitRep, or ?:

Situation Report

Read more about US increasingly unlikely to meet Biden’s July 4 vaccination goal
Log in or register to post comments

Pfizer to test COVID-19 vaccine for children under 12

Tue, 2021-06-08 10:23 — mike kraft

Pfizer to start large study to test COVID-19 vaccine in children below 12 Pfizer Inc said on Tuesday it will start a large study to test its COVID-19 vaccine in children below 12 and selected a dosing regime for the trial. Reuters Staff U.S.

(Reuters) - Pfizer Inc said on Tuesday it will start a large study to test its COVID-19 vaccine in children below 12 and selected a dosing regime for the trial.

Country / Region Tags:

General Topic Tags: